Robust and ICH-validated UV-Vis spectrophotometric method for the determination of benfotiamine in bulk substance, formulated products, and plasma using Bratton-Marshall chemistry

K. Bhavya Sri; Chaitanya K; Duddagi Suchitra; Sukanya Mandala; Pavan Kumar  Kasu

doi:10.69857/joapr.v14i2.1400

Authors

K. Bhavya Sri Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad-500027, Telangana, India
Chaitanya K Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad-500027, Telangana, India
Duddagi Suchitra Department of Pharmaceutical Analysis and Quality Assurance, Vision College of Pharmaceutical Sciences and Research, Boduppal, Hyderabad- 500092, India.
Sukanya Mandala Department of Pharmaceutical Analysis and Quality Assurance, Vision College of Pharmaceutical Sciences and Research, Boduppal, Hyderabad- 500092, India.
Pavan Kumar Kasu Department of Chemistry, University College of Sciences, Osmania University, Hyderabad- 500007, India.

DOI:

https://doi.org/10.69857/joapr.v14i2.1400

Keywords:

BM reagent, Benfotiamine, N-(1-naphthyl) ethylene diamine, UV Spectrophotometer, validation

Abstract

Background: Benfotiamine is widely used in the treatment of diabetic neuropathy and metabolic disorders. For the determination of pharmaceutical formulations and biological matrices, Spectrophotometry is widely employed in pharmaceutical analysis due to its simplicity and cost-effectiveness. The Bratton–Marshall reagent is used for Chromogenic reactions involving aromatic amines, producing colored complexes suitable for spectrophotometric quantification. The study aimed to develop and validate a simple, rapid, accurate, and precise UV–Visible spectrophotometric method for quantitative estimation of benfotiamine in bulk drug and human plasma using the Bratton–Marshall reagent. Methods: Benfotiamine was dissolved in 0.1 M hydrochloric acid and reacted with the BM reagent. In this reaction, sodium nitrite in an acidic medium diazotizes the primary aromatic amino group of benfotiamine, producing a pink Chromogenic exhibiting maximum absorbance at 550 nm. The Chromogenic method was further extended to a bioanalytical application for plasma samples. Protein precipitation was carried out using Acetonitrile to remove plasma proteins, followed by vortex mixing and centrifugation at 1000 rpm for 15 minutes. The resulting supernatant was analyzed spectrophotometrically. Results and Discussion: The developed method demonstrated linearity in the concentration range of 3–21 µg/ml with a correlation coefficient (R²) of 0.998. Accuracy ranged between 98.44% and 99.64%. Precision studies indicated %RSD values below 2% and remained within acceptable limits. The recovery of benfotiamine from human plasma was 98.91%, and the matrix effect showed acceptable variability. Conclusion: The proposed method is rapid, precise, and reliable for the quantification of benfotiamine in pharmaceutical and plasma samples.

Downloads

Download data is not yet available.

References

Bhavyasri K, Nandhini M. Simultaneous method development and validation of combined dosage form dapagliflozin and vildagliptin in bulk and combined tablet dosage form by UV spectrophotometry. Asian J. Pharm. Clin. Res., 17, 53–59 (2024) https://doi.org/10.22159/ajpcr.2024.v17i4.49083

Kumar S, Varadan S, P V, Sekar V, Singh T, Singh RS. Prevalence of vitamin B12 deficiency and its associated neuropathy in patients taking long term metformin therapy in type 2 diabetes mellitus. J. Appl. Pharm. Res., 11, 39–43 (2023) https://doi.org/10.18231/j.joapr.2023.11.5.39.43

Bhavyasri K, Vaishnavi A, Pravallika J, Sumakanth M. RP-HPLC-UV method for estimation of valaciclovir in dosage form and spiked human plasma using MBTH reagent as per ICH guidelines. Accredit. Qual. Assur., 30, 1–10 (2025) https://doi.org/10.1007/s00769-025-01500-x

Syed IB, Nannapaneni M. Bioanalytical method for the simultaneous estimation of atoltivimab, maftivimab and odesivimab in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. J. Appl. Pharm. Res., 12, 99–113 (2024) https://doi.org/10.69857/joapr.v12i4.607

Varsha MS, Raghavendra Babu N, et al. Development of spectrophotometric method for estimation of tenofovir disoproxil fumarate using MBTH reagent. Int. Curr. Pharm. J., 4, 378–381 (2015) https://doi.org/10.3329/icpj.v4i4.22673

Bhavyasri K, Fatima A, Sumakanth M. Method development, validation and forced degradation studies of fluphenazine using UV spectrophotometric method. Int. J. Biol. Pharm. Allied Sci., 10, 1281–1290 (2021) https://doi.org/10.31032/IJBPAS/2021/10.4.5413

Ghongade A, Barot S. Development and validation of stability indicating RP-HPLC method for nebivolol by using the DOE approach. J. Appl. Pharm. Res., 13, 179–191 (2025) https://doi.org/10.69857/joapr.v13i3.1062

Bhavya Sri K, Srija G, Sumakanth M. Reverse-phase high-performance liquid chromatography method development and validation for the quantification of sugammadex in bulk and pharmaceutical dosage form. Asian J. Pharm. Clin. Res., 17, 87–90 (2024) https://doi.org/10.22159/ajpcr.2024.v17i7.49862

Agrawal OD, Telang NB. Development and validation of UV spectrophotometric method for estimation of benfotiamine in bulk and dosage form. Asian J. Pharm. Anal., 6, 133–137 (2016) https://doi.org/10.5958/2231-5675.2016.00021.4

Ermer J, Miller JH McB. Method validation in pharmaceutical analysis: a guide to best practice. J. Pharm. Biomed. Anal., 44, 505–514 (2007) https://doi.org/10.1016/j.jpba.2007.02.006

Ribani M, Bottoli CBG, Collins CH, Jardim ICSF, Melo LFC. Validation for chromatographic and electrophoretic methods. Quim. Nova, 27, 771–780 (2004) https://doi.org/10.1590/S0100-40422004000500017

Rozet E, Marini B, Hubert P. Advances in validation of analytical methods in pharmaceutical analysis. TrAC Trends Anal. Chem., 42, 157–167 (2013) https://doi.org/10.1016/j.trac.2012.09.007

Snyder LR, Kirkland JJ, Dolan JW. Introduction to modern liquid chromatography. J. Chromatogr. A, 1217, 7421–7423 (2010) https://doi.org/10.1016/j.chroma.2010.05.046

Kazakevich A, Lobrutto R. HPLC for pharmaceutical scientists. Wiley, 1, 1–640 (2007) https://doi.org/10.1002/9780470087954

Green JM. A practical guide to analytical method validation. Anal. Chem., 68, 305A–309A (1996) https://doi.org/10.1021/ac961912f

Sahoo SK, Choudhury PK, Murthy PN, Mishra US, Bisoyi SK, Kumar L. Systematic approach to develop and validate high performance liquid chromatographic method for efavirenz and its degradants. J. Appl. Pharm. Res., 12, 119–128 (2024) https://doi.org/10.69857/joapr.v12i3.586

Snyder LR, Carr PW. Hydrophobic-subtraction model for reversed-phase liquid chromatography. J. Chromatogr. A, 1060, 77–116 (2004) https://doi.org/10.1016/j.chroma.2004.08.108

Taylor JR. Validation of analytical methods. Anal. Chem., 55, 600–608 (1983) https://doi.org/10.1021/ac00254a003

Gorog S. The role of impurity profiling in pharmaceutical analysis. TrAC Trends Anal. Chem., 25, 755–761 (2006) https://doi.org/10.1016/j.trac.2006.05.011

Susararla KPC, Shelke O, Shorgar N. Quantification of oteseconazole in rat plasma using LC-MS/MS and its application to pharmacokinetic study. J. Appl. Pharm. Res., 12, 54–65 (2024) https://doi.org/10.69857/joapr.v12i4.485

Rao RN. Liquid chromatography in pharmaceutical analysis. J. Pharm. Biomed. Anal., 55, 725–734 (2011) https://doi.org/10.1016/j.jpba.2011.02.017

Anthemidis AN. Spectrophotometric methods in drug analysis. Microchem. J., 98, 66–72 (2011) https://doi.org/10.1016/j.microc.2011.01.009

Pena-Pereira F. Analytical trends in pharmaceutical analysis. TrAC Trends Anal. Chem., 29, 617–628 (2010) https://doi.org/10.1016/j.trac.2010.03.004

Saha P, Pandit B, Pramanik S, Shrestha B. A comprehensive review on the applications of chemometrics in analytical chemistry. J. Appl. Pharm. Res., 13, 1–16 (2025) https://doi.org/10.69857/joapr.v13i3.861

Bakshi M, Singh S. Development of validated stability-indicating assay methods. J. Pharm. Biomed. Anal., 28, 1011–1040 (2002) https://doi.org/10.1016/S0731-7085(02)00047-X

Rathore AS. Quality by design in analytical method development. TrAC Trends Anal. Chem., 27, 26–34 (2008) https://doi.org/10.1016/j.trac.2007.10.006

Rao RN, Nagaraju V. Analytical method validation in pharmaceutical industry. J. Pharm. Anal., 2, 1–12 (2012) https://doi.org/10.1016/j.jpha.2011.11.002

Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs—A review. J. Pharm. Anal., 4, 159–165 (2014) https://doi.org/10.1016/j.jpha.2013.09.003

Peters FT, Drummer OH, Musshoff F. Validation of new methods in forensic toxicology. Forensic Sci. Int., 165, 216–224 (2007) https://doi.org/10.1016/j.forsciint.2006.05.021

Niessen WMA. Progress in liquid chromatography–mass spectrometry instrumentation and its impact on high-throughput screening. J. Chromatogr. A, 1000, 413–436 (2003) https://doi.org/10.1016/S0021-9673(03)00599-5

Shrisunder N, Dhakad PK, Gilhotra R. Novel RP-HPLC method development and validation for precise quantification of prochlorperazine maleate in pharmaceutical dosage forms. J. Appl. Pharm. Res., 13, 112–122 (2025) https://doi.org/10.69857/joapr.v13i1.782

Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R. Quantitative bioanalytical methods validation and implementation. Pharm. Res., 24, 1962–1973 (2007) https://doi.org/10.1007/s11095-007-9291-7

Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD, Pittman KA, Spector S. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. J. Pharm. Sci., 81, 309–312 (1992) https://doi.org/10.1002/jps.2600810317

Wells DA. High throughput bioanalytical sample preparation: methods and automation strategies. J. Chromatogr. B, 848, 3–11 (2007) https://doi.org/10.1016/j.jchromb.2006.09.043

Gorog S. Critical review of reports on impurity and degradation profiling in pharmaceutical research. TrAC Trends Anal. Chem., 26, 12–17 (2007) https://doi.org/10.1016/j.trac.2006.10.011

Katta SR, Ramachandra Rao I, Punitha P, Siva Prasad T. LC-MS/MS characterization of stress degradation products of gilteritinib and establishment of HPLC method for analysis of process related impurities of gilteritinib. J. Appl. Pharm. Res., 12, 109–123 (2024) https://doi.org/10.18231/j.joapr.2024.12.2.109.123

Carr PW, Stoll DR, Wang X. Perspectives on recent advances in the speed of high-performance liquid chromatography. Anal. Chem., 81, 5342–5353 (2009) https://doi.org/10.1021/ac900587x

Mandhare S, Godge R, Vikhe A, Talole S. Development and validation of a QbD-based RP-HPLC method for vericiguat quantification. J. Appl. Pharm. Res., 12, 57–67 (2024) https://doi.org/10.18231/j.joapr.2024.12.2.57.67

Taverniers I, De Loose M, Van Bockstaele E. Trends in quality in the analytical laboratory: analytical method validation and quality assurance. TrAC Trends Anal. Chem., 23, 535–552 (2004) https://doi.org/10.1016/j.trac.2004.04.001

Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon PA, Dewe W, Feinberg M, Laurentie M, Mercier N, Muzard G, Valat L. Harmonization of strategies for validation of quantitative analytical procedures. J. Pharm. Biomed. Anal., 36, 579–586 (2004) https://doi.org/10.1016/j.jpba.2004.07.005